CV Sciences (CVSI) Return on Capital Employed Growth (3y) (2014 - 2026)
CV Sciences (CVSI) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -9,232.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9,232.00 |
| Mar 31, 2026 | -5,543.00 |
| Dec 31, 2025 | 103,862.00 |
| Sep 30, 2025 | 66,247.00 |
| Jun 30, 2025 | 40,145.00 |
| Mar 31, 2025 | 36,413.00 |
| Dec 31, 2024 | 40,014.00 |
| Sep 30, 2024 | 30,137.00 |
| Jun 30, 2024 | 3,543.00 |
| Mar 31, 2024 | 2,429.00 |
| Dec 31, 2023 | 21,358.00 |
| Sep 30, 2023 | 12,672.00 |
| Jun 30, 2023 | 8,931.00 |
| Mar 31, 2023 | 4,242.00 |
| Dec 31, 2022 | -102,075.00 |
| Sep 30, 2022 | -68,428.00 |
| Jun 30, 2022 | -44,813.00 |
| Mar 31, 2022 | -42,492.00 |
| Dec 31, 2021 | -32,391.00 |
| Sep 30, 2021 | -17,157.00 |